Protalix Biotherapeutics Inc
AMEX:PLX
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
P
|
Protalix Biotherapeutics Inc
AMEX:PLX
|
US |
|
SolGold PLC
LSE:SOLG
|
AU |
|
N
|
Nature and Environment Co Ltd
KOSDAQ:043910
|
KR |
|
Andersons Inc
NASDAQ:ANDE
|
US |
|
Union Steel Holdings Ltd
SGX:BLA
|
SG |
|
R
|
Radiopharm Theranostics Ltd
ASX:RAD
|
AU |
|
Reliance Industries Ltd
NSE:RELIANCE
|
IN |
Wall Street
Price Targets
PLX Price Targets Summary
Protalix Biotherapeutics Inc
According to Wall Street analysts, the average 1-year price target for PLX is 11.22 USD with a low forecast of 10.1 USD and a high forecast of 12.6 USD.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is PLX's stock price target?
Price Target
11.22
USD
According to Wall Street analysts, the average 1-year price target for PLX is 11.22 USD with a low forecast of 10.1 USD and a high forecast of 12.6 USD.
What is Protalix Biotherapeutics Inc's Revenue forecast?
Projected CAGR
11%
For the last 13 years the compound annual growth rate for Protalix Biotherapeutics Inc's revenue is 25%. The projected CAGR for the next 3 years is 11%.
What is Protalix Biotherapeutics Inc's Operating Income forecast?
Projected CAGR
18%
The compound annual growth rate of Protalix Biotherapeutics Inc's operating income for the next 3 years is 18%.
What is Protalix Biotherapeutics Inc's Net Income forecast?
Projected CAGR
30%
The compound annual growth rate of Protalix Biotherapeutics Inc's net income for the next 3 years is 30%.
